Misty Ward Stevens

Misty Ward Stevens has held various roles within the biotechnology sector. Misty is currently serving as the Chief Operating Officer at Kuria Therapeutics since February 2022. Prior to this, Misty worked at InterveXion Therapeutics, where they also held the position of Chief Operating Officer from June 2019. Misty was previously an Operations Director at the same company from April 2007 to May 2019 and started their career there as a Staff Scientist from June 2005 to April 2007. Prior to joining InterveXion Therapeutics, Misty worked as a Postdoctoral Fellow at Harvard Medical School from September 2003 to June 2005.

Misty Ward Stevens earned their Ph.D. in Biology from the University of Arkansas, where they attended from 1999 to 2003. Later on, they pursued an MBA with a focus on Management from the same institution, studying from 2008 to 2010.